Core 1: Functional Genomics and Proteomics
核心1:功能基因组学和蛋白质组学
基本信息
- 批准号:10525592
- 负责人:
- 金额:$ 32.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-14 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AffinityAffinity ChromatographyAtlas of Cancer Mortality in the United StatesBioinformaticsBiological AssayBiological SciencesBreastCRISPR/Cas technologyCancer ModelCancer cell lineCell LineCell modelCellsClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsComplexComputational BiologyCore FacilityCoupledCryoelectron MicroscopyDataDependenceDiseaseEducationEducation and OutreachGenerationsGenesGeneticGenetic ScreeningGenomic medicineGenomicsGoalsHead and Neck Squamous Cell CarcinomaHead and neck structureInfrastructureInstitutesKnock-inKnock-outLeadLungMaliMalignant NeoplasmsMalignant neoplasm of lungMapsMass Spectrum AnalysisMeasuresMentorsModelingMolecularMutateMutationOutcomePathogenesisPathologyPathway AnalysisPathway interactionsPhenotypePhysiologicalPoint MutationProtein Complex SubunitProteinsProteomicsRecurrenceReproducibilityResearch PersonnelResearch Project GrantsResearch SupportSpecificityStructureSystems BiologyTP53 geneTechnical ExpertiseTechnologyTertiary Protein StructureVariantbasecancer cellcancer typecell typecombinatorialcomparativecrosslinkexperimental studyfitnessfunctional genomicsinsightinterestloss of functionmigrationmutantnetwork modelsnovelpatient stratificationprotein complexprotein expressionprotein functionprotein protein interactionprotein structurereverse geneticssoftware infrastructurestoichiometrytargeted cancer therapytargeted treatmenttumor progressiontumorigenesis
项目摘要
CCMI v2.0
Core 1: Functional Genomics and Proteomics Core
Core Lead: Nevan Krogan; Co-Investigator: Prashant Mali
SUMMARY
Systematic characterization of protein-protein interactions (PPIs) and genetic interaction networks of cancer
drivers is critical for the identification of functional complexes for patient stratification and targeted cancer
therapies. Proteomic approaches that determine PPIs and protein complex stoichiometry and topology can
provide strategic insight into the dynamic cancer landscape and help guide tailored genetic screens to assess
functional relevance of newly characterized PPIs. The Functional Genomics and Proteomics Core (Core 1)
will provide the infrastructure and technical expertise essential to the completion of the overall CCMI objectives.
With support of two Core facilities, the Functional Genomics and Proteomics Core will provide its expertise
in CRISPR genetic screens (Institute for Genomic Medicine (IGM) Genomics Center, UCSD) and proteomic
technologies (Thermo Fisher Scientific Proteomics Facility for Disease Target Discovery, UCSF, Quantitative
Biosciences Institute (QBI), Gladstone Institute) for the generation of high-quality protein-protein (Aim 2; in
support of Project 1) and genetic (Aim 1; in support of Project 2) interaction data, which will be integrated using
systems biology approaches in Project 3 and Core 2. Our goal is to provide functional and structural
characterization of cancer driver networks, model their functional interactions in three different cancers (breast,
head and neck, lung cancer), and determine consequences of introducing point mutations. Finally, we will use a
unique platform for Endogenous Network/Dynamic Structure (EN/DS) determination (Aim 3) that will use
CRISPR-based genetics to introduce point mutations and FLAG-affinity tags into the endogenous loci of selected
genes to study endogenous protein complex stoichiometry and structure using mass spectrometry and cryo-EM
(in support of Project 1).
CCMI v2.0
核心1:功能基因组学和蛋白质组学
核心负责人:Nevan Krogan;合作研究者:Prashant Mali
总结
蛋白质-蛋白质相互作用(PPI)的系统表征和癌症的遗传相互作用网络
驱动因子对于识别患者分层和靶向癌症的功能复合物至关重要
治疗确定PPI和蛋白质复合物化学计量和拓扑结构的蛋白质组学方法可以
提供对动态癌症格局的战略洞察,并帮助指导量身定制的基因筛查来评估
新表征PPI的功能相关性。功能基因组学和蛋白质组学核心(核心1)
将提供完成CCMI总体目标所必需的基础设施和技术专长。
在两个核心设施的支持下,功能基因组学和蛋白质组学核心将提供其专业知识,
CRISPR基因筛选(基因组医学研究所(IGM)基因组学中心,UCSD)和蛋白质组学
技术(Thermo Fisher Scientific Proteomics Facility for Disease Target Discovery,UCSF,Quantitative
生物科学研究所(QBI),Gladstone研究所)用于产生高质量的蛋白质-蛋白质(Aim 2;在
支持项目1)和遗传(目标1;支持项目2)相互作用数据,将使用
项目3和核心2中的系统生物学方法。我们的目标是提供功能和结构
表征癌症驱动网络,在三种不同的癌症(乳腺癌,
头颈癌、肺癌),并确定引入点突变后果。最后,我们将使用
用于确定内生网络/动态结构(EN/DS)的独特平台(目标3),将使用
基于CRISPR的遗传学将点突变和FLAG亲和标签引入所选的内源基因座,
基因,使用质谱和cryo-EM研究内源性蛋白质复合物的化学计量和结构
(in支持项目1)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nevan J Krogan其他文献
Nevan J Krogan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nevan J Krogan', 18)}}的其他基金
HARC: HIV accessory and regulatory complexes
HARC:HIV 附件和调节复合体
- 批准号:
10506980 - 财政年份:2022
- 资助金额:
$ 32.62万 - 项目类别:
International West Africa Symposium and Workshop on Infectious Diseases
国际西非传染病研讨会暨讲习班
- 批准号:
10540552 - 财政年份:2022
- 资助金额:
$ 32.62万 - 项目类别:
HARC: HIV accessory and regulatory complexes
HARC:HIV 附件和调节复合物
- 批准号:
10666644 - 财政年份:2022
- 资助金额:
$ 32.62万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 32.62万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 32.62万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 32.62万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 32.62万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 32.62万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 32.62万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 32.62万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 32.62万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 32.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 32.62万 - 项目类别:
Collaborative Research and Development Grants